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ABSTRACT: We previously reported that a decrease in the melanin content of mouse 
melanoma cells (B16 cells) treated with δ-tocotrienol was the result of a decrease in the level 
of tyrosinase activity and protein. Use of δ-tocotrienol as a whitening agent, may therefore 
have side effects. In the present study, we examined whether δ-tocotrienol caused side effects 
(the release of lysosomes from and a decrease in the cholesterol content of cells). We also 
examined the release of melanosomes (lysosome-related organella). Neither of lysosomes 
nor melanosomes were released from cells treated with δ-tocotrienol, since β-glucuronidase 
(melanosomal and lysosomal enzyme) activity, melanin content (melanosomal marker), 
and tyrosinase (melanosomal enzyme) activity did not increase in the cell culture medium. 
Although mevalonate pyrophosphate decarboxylase (MPD; an enzyme of cholesterol 
biosynthesis) was significantly reduced in the cells treated with δ-tocotrienol, cholesterol 
content was not. Thus, δ-tocotrienol might be useful as a therapeutic or preventive drug for 
hyperpigmentation and as a component of whitening and/or lightening cosmetics not causing 
severe side effect (reduction of cholesterol content and release of lysosomes/melanosomes), 
although δ-tocotrienol cause a decrease of MPD.  
抄録　デルタ‐トコトリエノールは、コレステロール合成酵素の１つであるメバロン
酸二リン酸脱炭酸酵素の減少を引き起こすけれども、リソソームやメラノソームの放
出とコレステロール含量の低下には関与していない。
